Inhibition of cytochrome P450 2E1 decreases, but does not eliminate, genotoxicity mediated by 1,3-butadiene

被引:21
作者
Jackson, TE
Lilly, PD
Recio, L
Schlosser, PM
Medinsky, MA
机构
[1] Chem Ind Inst Toxicol, Res Triangle Pk, NC 27709 USA
[2] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC USA
关键词
1,3-butadiene; CYP2E1; genotoxicity; micronuclei; gas uptake;
D O I
10.1093/toxsci/55.2.266
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
1,3-Butadiene (BD), a rodent carcinogen, is metabolized to mutagenic and DNA-reactive epoxides. In vitro data suggest that this oxidation is mediated by cytochrome P450 2E1 (CYP2E1). In this study, we tested the hypothesis that oxidation of ED by CYP2E1 is required for genotoxicity to occur. Inhalation exposures were conducted with B6C3F1 mice using a closed-chamber technique, and the maximum rate of butadiene oxidation was estimated. The total amount of butadiene metabolized was then correlated with the frequency of micronuclei (MN), Three treatment groups were used: (1) mice with no pretreatment; (2) mice pretreated with 1,2-trans-dichloroethylene (DCE), a specific CYP2E1 inhibitor; and (3) mice pretreated with 1-aminobenzotriazole (ABT), an irreversible inhibitor of cytochromes P450, Mice in all 3 groups were exposed to an initial ED concentration of 1100 ppm, and the decline in concentration of ED in the inhalation chamber with time, due to uptake and metabolism of ED, was monitored using gas chromatography, A physiologically based pharmacokinetic model was used to analyze the gas uptake data, estimate V-max for ED oxidation, and compute the total amount of ED metabolized, Model simulations of the gas uptake data predicted the maximum rate of ED oxidation would be reduced by 60% and 100% for the DCE- and ABT-pretreated groups, respectively. Bone marrow was harvested 24 h after the onset of the inhalation exposure and analyzed for frequency of micronuclei in polychromatic erythrocytes (MN-PCE). The frequency of MN-PCE per 1000 PCE in mice exposed to ED was 28.2 +/- 3.1, 19.8 +/- 2.5, and 12.3 +/- 1.9, for the mice with no pretreatment, DCE-pretreated mice and ABT-pretreated mice, respectively. Although inhibition of CYP2E1 decreased ED-mediated genotoxicity, it did not completely eliminate genotoxic effects, These data suggest that other P450 isoforms may contribute significantly to the metabolic activation of ED and resultant genotoxicity.
引用
收藏
页码:266 / 273
页数:8
相关论文
共 46 条
[1]   DETERMINATION OF THE KINETIC CONSTANTS FOR METABOLISM OF INHALED TOXICANTS INVIVO USING GAS UPTAKE MEASUREMENTS [J].
ANDERSEN, ME ;
GARGAS, ML ;
JONES, RA ;
JENKINS, LJ .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1980, 54 (01) :100-116
[2]  
[Anonymous], IND MARKETING PURCHA
[3]   INDUCTION OF MICRONUCLEI IN PERIPHERAL-BLOOD AND BONE-MARROW ERYTHROCYTES OF RATS AND MICE EXPOSED TO 1,3-BUTADIENE BY INHALATION [J].
AUTIO, K ;
RENZI, L ;
CATALAN, J ;
ALBRECHT, OE ;
SORSA, M .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1994, 309 (02) :315-320
[4]   EFFECTS OF DISULFIRAM ON HEPATIC P450IIE1, OTHER MICROSOMAL-ENZYMES, AND HEPATOTOXICITY IN RATS [J].
BRADY, JF ;
XIAO, F ;
WANG, MH ;
LI, Y ;
NING, SM ;
GAPAC, JM ;
YANG, CS .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 108 (02) :366-373
[5]   ANALYSIS OF 1,3-BUTADIENE AND OTHER SELECTED GAS-PHASE COMPONENTS IN CIGARETTE MAINSTREAM AND SIDESTREAM SMOKE BY GAS-CHROMATOGRAPHY MASS SELECTIVE DETECTION [J].
BRUNNEMANN, KD ;
KAGAN, MR ;
COX, JE ;
HOFFMANN, D .
CARCINOGENESIS, 1990, 11 (10) :1863-1868
[6]   ETHOXYPHENOXAZONES, PENTOXYPHENOXAZONES, AND BENZYLOXYPHENOXAZONES AND HOMOLOGS - A SERIES OF SUBSTRATES TO DISTINGUISH BETWEEN DIFFERENT INDUCED CYTOCHROMES-P-450 [J].
BURKE, MD ;
THOMPSON, S ;
ELCOMBE, CR ;
HALPERT, J ;
HAAPARANTA, T ;
MAYER, RT .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (18) :3337-3345
[7]   EVALUATION OF TRIACETYLOLEANDOMYCIN, ALPHA-NAPHTHOFLAVONE AND DIETHYLDITHIOCARBAMATE AS SELECTIVE CHEMICAL PROBES FOR INHIBITION OF HUMAN CYTOCHROMES P450 [J].
CHANG, TKH ;
GONZALEZ, FJ ;
WAXMAN, DJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 311 (02) :437-442
[8]   MUTAGENICITY OF BUTADIENE AND ITS EPOXIDE METABOLITES .1. MUTAGENIC POTENTIAL OF 1,2-EPOXYBUTENE, 1,2,3,4-DIEPOXYBUTANE AND 3,4-EPOXY-1,2-BUTANEDIOL IN CULTURED HUMAN LYMPHOBLASTS [J].
COCHRANE, JE ;
SKOPEK, TR .
CARCINOGENESIS, 1994, 15 (04) :713-717
[9]   INDUCTION AND RAPID REPAIR OF SISTER-CHROMATID EXCHANGES IN MULTIPLE MURINE TISSUES INVIVO BY DIEPOXYBUTANE [J].
CONNER, MK ;
LUO, JE ;
DEGOTERA, OG .
MUTATION RESEARCH, 1983, 108 (1-3) :251-263
[10]   CANCER RISK ASSESSMENT OF 1,3-BUTADIENE [J].
COTE, IL ;
BAYARD, SP .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1990, 86 :149-153